Onipede A, Odetoyin B, Ojo O, Adejobi A
Department of Medical Microbiology and Parasitology, Obafemi Awolowo University, Ile-Ife, Nigeria.
Department of Natural Sciences, Albany State University, Albany GA, USA.
West Afr J Med. 2021 Nov 30;Vol. 38(11):1072-1079.
Metallo-beta-lactamase producingPseudomonas aeruginosa (MBL-PA) infections pose a major healthcare concern globally due to the associated extended morbidity, increased cost of treatment and high mortality.
This study aimed to determine the prevalence of circulating MBL-PA strains and evaluate probable risk factors associated with the carriage of MBL-PA among patients in a selected South-western tertiary hospital in Nigeria.
One hundred and forty-four isolates recovered from diverse clinical specimens were identified as Pseudomonas aeruginosa by conventional methods. Eight antibiotics were tested on the isolates using Kirby-Bauer disc diffusion technique. All carbapenem resistant isolates were phenotypically screened for MBL-production using the combined disc synergy test. The MBL-producing strains were evaluated for the presence of three MBL genes blaIMP, blaVIM-2 and blaNDM1 by Polymerase chain reaction (PCR).
Fourteen (9.7%) isolates were positive for metallobeta-lactamase production by combined disc synergy test. The MBL-producing strains were more commonly resistant to all the tested antibiotics except to piperacillin tazobactam and imipenem compared with the non MBL producing strains (p<0.05). Antibiotic use and the occurrence of multidrug resistance phenotype were significantly associated with MBLcarriage (p<0.05). Four (28.6%) MBL-PA isolates carried NDM-1 gene, while IMP and VIM-2 genes were not detected in any of the isolates.
The study demonstrated a low prevalence of NDM-1 in P. aeruginosa circulating among patients in this environment. This may be because carbapenems are seldom prescribed in our hospital or probably due to the existence of other MBL genes and non-enzymatic resistance mechanisms that we did not investigate. Studies that evaluate the level of carbapenem resistance via non-MBL production route could assist and improve future surveillance of these fast spreading genes.
产金属β-内酰胺酶的铜绿假单胞菌(MBL-PA)感染因相关的发病率延长、治疗成本增加和高死亡率,在全球范围内引起了重大的医疗关注。
本研究旨在确定循环MBL-PA菌株的流行率,并评估尼日利亚西南部一家选定的三级医院患者中与MBL-PA携带相关的可能风险因素。
通过常规方法从不同临床标本中分离出的144株菌株被鉴定为铜绿假单胞菌。使用 Kirby-Bauer 纸片扩散技术对分离株进行了8种抗生素的测试。所有耐碳青霉烯类分离株均使用联合纸片协同试验进行MBL产生的表型筛选。通过聚合酶链反应(PCR)评估产MBL菌株中三种MBL基因blaIMP、blaVIM-2和blaNDM1的存在情况。
联合纸片协同试验显示,14株(9.7%)分离株产金属β-内酰胺酶呈阳性。与非产MBL菌株相比,产MBL菌株对除哌拉西林他唑巴坦和亚胺培南外的所有测试抗生素更具耐药性(p<0.05)。抗生素使用和多重耐药表型的出现与MBL携带显著相关(p<0.05)。4株(28.6%)MBL-PA分离株携带NDM-1基因,而在任何分离株中均未检测到IMP和VIM-2基因。
该研究表明,在这种环境下患者中循环的铜绿假单胞菌中NDM-1的流行率较低。这可能是因为我们医院很少使用碳青霉烯类药物,或者可能是由于存在其他我们未研究的MBL基因和非酶耐药机制。通过非MBL产生途径评估碳青霉烯类耐药水平的研究可以帮助并改善对这些快速传播基因的未来监测。